• Users Online: 341
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Archives Submit article Instructions Referee Resource Subscribe
REVIEW ARTICLE
Year : 2022  |  Volume : 9  |  Issue : 2  |  Page : 80-86

GnRH agonist trigger in modern reproductive medicine practice − when, why, and how?


1 Senior Clinical Fellow in OBGY, Manchester University Hospitals NHS Trust, Manchester, UK
2 Specialty Doctor in OBGY, Manchester University Hospitals NHS Trust, Manchester, UK
3 Consultant in Reproductive Medicine, Manchester University Hospitals NHS Trust, Manchester, UK

Correspondence Address:
Deepti Gupta
10 Ripon Groove, Sale, M33 5GZ, Manchester, United Kingdom
UK
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/fsr.fsr_26_22

Rights and Permissions

The use of gonadotropin-releasing hormone (GnRH) antagonist protocols in assisted conception is a major advance in modern reproductive medicine practice. Specifically, the application of GnRH agonist (GnRHa) as the final trigger for oocyte maturation in cycles where GnRH antagonist has been used is associated with a significant reduction in the risk of developing one of the most serious iatrogenic complications of assisted conception, ovarian hyperstimulation syndrome. GnRHa trigger has been shown to be as effective as human chorionic gonadotropin trigger with respect to oocyte yield and maturity in both autologous and donor cycles in multiple studies. This trigger, however, results in poor corpus luteum development and consequently luteal phase dysfunction and impaired endometrial receptivity. In this review, we address the indications, contraindications, outcomes, and practical considerations when using the GnRHa trigger.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed305    
    Printed8    
    Emailed0    
    PDF Downloaded44    
    Comments [Add]    

Recommend this journal